Latest Tag: Biosafety Resources

Resistance against “bogus” drought tolerant (DT) maize in South Africa: a snapshot of two decades of activism

In 2023, on 7-8 February, the ACB finally had a court hearing in the High Court in Pretoria, after five years of protracted legal proceedings since we lodged the application for a review. The aim has been to overturn the decisions of the South African Executive Council: GMO Act (EC), the GMO Appeal Board, and […]

GLOBAL BIODIVERSITY FRAMEWORK AND SYNTHETIC BIOLOGY: MISSED OPPORTUNITY FOR BIOSAFETY AND BIODIVERSITY PROTECTION FOR AFRICA

– By ACB Research and Advocacy Officer Sabrina Masinjila & Executive Director Mariam Mayet For several years, the ACB has engaged at multiple levels with the development of the Post-2020 Global Biodiversity Framework (GBF). In the lead up to the Convention on Biological Diversity (CBD) Conservation’s fifteenth Conference of Parties (COP 15), held in Montreal, Canada in […]

ACB at the 2022 UN Biodiversity Conference (COP 15)

The 2022 UN Biodiversity Conference (COP 15) was held in Montreal, Canada, 7-19 December. Governments from around the world came together to work towards an agreement on a new set of goals to guide global action through 2030 to halt and reverse nature loss. The Kunming-Montreal Global Biodiversity Framework (GBF) was adopted during COP 15 […]

JUDGMENT ON ACB’S HIGH COURT REVIEW OF MONSANTO’S ALLEGED DROUGHT TOLERANT GM TRAIT PENDING

On Tuesday and Wednesday this week, 7-8 February, the ACB’s case was heard in the High Court. Five years earlier, the ACB lodged the application for this review, to overturn the decisions of the South African Executive Council (EC): Genetically Modified Organisms (GMO) Act, the GMO Appeal Board, and the Minister of Agriculture, Forestry and […]

Landmark legal challenge against Monsanto/ Bayer’s “bogus” drought tolerant GM maize finally to be heard in South African High Court

In 2017, the African Centre for Biodiversity (ACB) lodged legal proceedings with the High Court of South Africa to review and overturn the decisions of the South African Executive Council: GMO Act (EC), the GMO Appeal Board, and the Minister of Agriculture, Forestry and Fisheries, approving Monsanto/Bayer’s genetically modified (GM) drought-tolerant (DT) maize variety MON […]

The battle over regulation of new breeding techniques in South Africa

– A blog by ACB Director Mariam Mayet Snapshot In October 2021, the South African (SA) government determined that the regulatory and risk assessment framework that exists for genetically modified organisms (GMOs) will also apply to new breeding techniques (NBTs), which make up a host of new genetic engineering technologies. This decision appears to follow […]

Will GM cane be the icing on South Africa’s masterplan for sugar?

The ACB was shocked to discover that over the past years research has been conducted for the application for field trials of a genetically modified (GM) insect-resistant (Bt) and herbicide-tolerant (Ht) sugar cane variety, primarily as protection against the lepidopteran stalk borer Eldana saccharina. As we report in our new alert, in the same timeframe, […]

Is the end of the State of Disaster the beginning of mandatory vaccines in South Africa?

The endless extensions to the State of Disaster, initially declared two years ago, has provoked criticism from medical experts and calls for its end from public-interest groups and an increasingly fed-up citizenry. Recently, the government announced that the restrictions were finally to be lifted.  However, during this time, a draft amendment to the National Health […]

Coalition demands a ban of Bt Cowpea in Nigeria and neighbouring West African countries

A coalition of non-governmental organisations, farmer groups and research experts from various African countries call on the Nigerian government to revoke the permits granted by Nigeria’s National Biosafety Management Agency (NBMA) to the Institute for Agricultural Research (IAR), Zaria, for the commercial release of genetically modified (Bt) Cowpea (PBR-Cowpea). This call was made yesterday in […]

ACB raises concerns on GM Covid-19 vaccine trials for SA, calls for transparency & public hearings

Clique aqui para a versão portuguesa Por favor, haga clic aquí para el español The African Centre for Biodiversity (ACB) has made a submission to the Registrar of GMOs in South Africa, following an application made by Professor Shabir Ahmed Madhi, from the Respiratory and Meningeal Pathogens Research Unit (RMPRU), Chris Hani Baragwanath Academic Hospital, […]

COVID-19: Access to medicine & implications for Africa

ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]

ALERT: More poisoning of South Africa’s staple food, as 2,4-D GM maize set for approval

6 September 2019 The African Centre for Biodiversity (ACB) is extremely concerned about impending approvals by the South African government in regard to three new genetically modified (GM) maize varieties designed to withstand the extremely toxic herbicide, 2,4-D. 2,4-D is one of the active ingredients of the infamous war chemical Agent Orange. The ACB has […]